Are Infant Reflux Drugs Worth the Risks?

November 19, 2012 | By

The number of babies prescribed acid suppression drugs such as H2 blockers and PPIs grew 8-fold during 2002 to 2009, but fewer than 10% received any diagnostic testing for GERD (Gastroesophageal Reflux Disease). Some pediatricians are growing concerned that the “epidemic” of infant GERDcases is actually due to over-diagnosis, especially since clinical trials show acid blockers work no better than a placebo and can actually lead to short term and long term side effects. The FDA has not approved PPIs for treatment of GERD in children younger than one year. Learn more in the following infographic from Colic Calm.

[Click here for full size version]

Are Infant Reflux Drugs Worth the Risks?

email

Filed in: Health Infographics

About the Author (Author Profile)

Co-founder and Vice President of SearchRank, responsible for many of the day to day operations of the company. She is also founder of The Arizona Builders' Zone, a construction / home improvement portal. Follow +Irma Wallace on Google + as well as Twitter.

Comments are closed.